Study of the cognitive effects of chemotherapy: Considerations in selection of a control group

Journal of Clinical and Experimental Neuropsychology

Volumn 35, Issue 4, 2013, Pages 435-444

  Collins, Barbara ^a   Mackenzie, Joyce ^a   Kyeremanteng, Catherine ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Breast cancer; Chemotherapy; Cognition; Control group; Methodological issues; Practice effect

Indexed keywords

EID: 84876802142     PISSN: 13803395     EISSN: 1744411X     Source Type: Journal    
DOI: 10.1080/13803395.2013.781995     Document Type: Article

References (64)

1. Ahles, T. A., Saykin, A. J., Furstenberg, C. T., Cole, B., Mott, L. A., Skalla, K., Silverfarb, P. M. (2002). Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. Journal of Clinical Oncology, 20, 485-493. doi:10.1200/JCO.20.2.485
2. Ahles, T. A., Saykin, A. J., McDonald, B. C., Furstenberg, C. T., Cole, B. F., Hanscom, B. S., Kaufman, P. A. (2008). Cognitive function in breast cancer patients prior to adjuvant treatment. Breast Cancer Research and Treatment, 110, 143-152. doi:10.1007/s10549-007-9686-5
3. Ahles, T. A., Saykin, A. J., McDonald, B. C., Li, Y., Furstenberg, C. T., Hanscom, B. S., Kaufman, P. A. (2010). Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: Impact of age and cognitive reserve. Journal of Clinical Oncology, 28, 4434-4440. doi:10.1200/JCO. 2009.27.0827
4. Army Individual Test Battery. (1944). Manual for directions and scoring. Washington, DC: War Department, Adjutant General's Office.
5. Bender, C. M., Sereika, S. M., Berga, S. L., Vogel, V. G., Brufsky, A. M., & Paraska, K. K. (2006). Cognitive impairment associated with adjuvant therapy in breast cancer. Psycho-Oncology, 15, 422-430. doi:10.1002/pon.964
6. Bender, C. M., Sereika, S. M., Brufsky, A. M., Ryan, C. M., Vogel, V. G., Rastogi, P., Berga, S. L. (2007). Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer. Menopause, 14, 995-998. doi:10.1097/gme.0b013e318148b28b
7. Benton, A. L., Hamsher, K., & Sivan, A. B. (1994). Multilingual Aphasia Examination (3rd ed.). Iowa City, IA: AJA.
8. Biglia, N., Moggio, G., Peano, E., Sgandurra, P., Ponzone, R., Nappi, R. E., & Sismondi, P. (2010). Effects of surgical and adjuvant therapies for breast cancer on sexuality, cognitive functions and body weight. The Journal of Sexual Medicine, 7, 1891-1900. doi:10.1111/j.1743-6109.2010.01725.x
9. Brezden, C., Phillips, K. A., Bunston, T., & Tannock, I. F. (2000). Cognitive function in breast cancer patients receiving adjuvant chemotherapy. Journal of Clinical Oncology, 18, 2695-2701.
10. Buckwalter, J. G., Crooks, V. C., & Petitti, D. B. (2005). Cognitive performance of older women who have survived cancer. International Journal of Neuroscience, 115, 1307-1314. doi:10.1080/00207450590934534
11. Castellon, S. A., Ganz, P. A., Bower, J. E., Petersen, L., Abraham, L., & Greendale, G. A. (2004). Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. Journal of Clinical and Experimental Neuropsychology, 26, 955-969. doi:10.1080/13803390490510905
12. Cimprich, B., Reuter-Lorenz, P., Nelson, J., Clark, P. M., Therrien, B., Normolle, D., Welsh, R. C. (2010). Pre-chemotherapy alterations in brain function in women with breast cancer. Journal of Clinical and Experimental Neuropsychology, 32, 324-331. doi:10.1080/13803390903032537
13. Cimprich, B., & Ronis,D. L. (2001). Attention and symptom distress in women with and without breast cancer. Nursing Research, 50, 86-94. doi:10.1097/00006199-200103000-00004
14. Collins, B., MacKenzie, J., Stewart, A., Bielajew, C., & Verma, S. (2009). Cognitive effects of chemotherapy in post-menopausal breast cancer patients one year after treatment. Psycho-Oncology, 18, 134-143. doi:10.1002/pon.1379
15. Delis, D. C., Kramer, J. H., Kaplan, E., & Ober, B. A. (2000). California Verbal Learning Test II manual. San Antonio, TX: Psychological Corporation.
16. Dikmen, S. S., Heaton, R. K., Grant, I., & Temkin, N. R. (1999). Test-retest reliability and practice effects of expanded Halstead-Reitan Neuropsychological Test Battery. Journal of the International Neuropsychological Society, 5, 346-356.
17. Donovan, K. A., Small, B. J., Andrykowski, M. A., Schmitt, F. A., Munster, P., & Jacobsen, P. B. (2005). Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma. Cancer, 104, 2499-2507. doi:10.1002/cncr.21482
18. Eberling, J. L., Wu, C., Tong-Turnbeaugh, R., & Jagust, W. J. (2004). Estrogen- and tamoxifen-associated effects on brain structure and function. NeuroImage, 21, 364-371. doi:10.1016/j.neuroimage.2003.08.037
19. Falleti, M. G., Sanfilippo, A., Maruff, P., Weih, L., & Phillips, K.-A. (2005). The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: A metaanalysis of the current literature. Brain and Cognition, 59, 60-70. doi:10.1016/j.bandc.2005.05.001
20. Flanagan, J. L., & Jackson, S. T. (1997). Test-retest reliability of three aphasia tests: Performance of non-brain-damaged older adults. Journal of Communication Disorders, 30, 33-43. doi:10.1016/S0021-9924%2896%2900039-1
21. Goodglass, H., Kaplan, E., & Weintraub, S. (1983). The Boston Naming Test (2nd ed.). Philadelphia, PA: Lea & Febiger.
22. Heaton, R. K. (1981). Wisconsin Card Sorting Test manual. Odessa, FL: Psychological Assessment Resources.
23. Hermelink, K., Untch, M., Lux, M. P., Kreienberg, R., Beck, T., Bauerfeind, I., & Münzel, K. (2007). Cognitive function during neoadjuvant chemotherapy for breast cancer: Results of a prospective, multicentre, longitudinal study. Cancer, 109, 1905-1913. doi:10.1002/cncr.22610
24. Horton, A. M. (1992). Neuropsychological practice effects related to age: A brief note. Perceptual and Motor Skills, 75, 257-258.
25. Hurria, A., Goldfarb, S., Rosen, C., Holland, J., Zuckerman, E., Lachs, M. S., Hudis, C. (2006). Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient's perspective. Breast Cancer Research and Treatment, 98, 343-348. doi:10.1007/s10549-006-9171-6
26. Iconomou, G., Mega, V., Koutras, A., Iconomou, A. V., & Kalofonos, H. P. (2004). Prospective assessment of emotional distress, cognitive function, and quality of life in patients with cancer treated with chemotherapy. Cancer, 101, 404-411. doi:10.1002/cncr.20385
27. Ingraham, L. J., & Aiken, C. B. (1996). An empirical approach to determining criteria for abnormality in test batteries with multiple measures. Neuropsychology, 10, 120-124. doi:10.1037/0894-4105.10.1.120
28. Jansen, C. E., Cooper, B. A., Dodd, M. J., & Miaskowski, C. A. (2011). A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients. Supportive Care in Cancer, 19, 1647-1656. doi:10.1007/s00520-010-0997-4
29. Jenkins, V., Shilling, V., Deutsch, G., Bloomfield, D., Morris, R., Allan, S., Winstanley, J. (2006). A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. British Journal of Cancer, 94, 828-834. doi:10.1038/sj.bjc.6603029
30. Jenkins, V., Shilling, V., Fallowfield, L., Howell, A., & Hutton, S. (2004). Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study. Psycho-Oncology, 13, 61-66. doi:10.1002/pon.709
31. Levine, A. J., Miller, E. N., Becker, J. T., Selnes, O. A., & Cohen, B. A. (2004). Normative data for determining significance of test-retest differences on eight common neuropsychological instruments. Clinical Neuropsychologist, 18, 373-384. doi:10.1080/1385404049052420
32. Lowe, C., & Rabbitt, P. (1998). Test/re-test reliability of the CANTAB and ISPOCD neuropsychological batteries: Theoretical and practical issues. Neuropsychologia, 36, 915-923.
33. McCaffrey, R. J., Duff, K., & Westervelt, H. J. (2000). Critical issues in neuropsychology: Practitioner's guide to evaluating change with neuropsychological assessment instruments. New York, NY: Kluwer Academic/Plenum.
34. Mehlsen, M., Pedersen, A. D., Jensen, A. B., & Zachariae, R. (2009). No indications of cognitive sideeffects in a prospective study of breast cancer patients receiving adjuvant chemotherapy. Psycho-Oncology, 18, 248-257. doi:10.1002/pon.1398
35. Meyers, C. A., Byrne, K. S., & Komaki, R. (1995). Cognitive deficits in patients with small cell lung cancer before and after chemotherapy. Lung Cancer, 12, 231-235.
36. Minisini, A. M., De Faccio, S., Ermacora, P., Andreetta, C., Fantinel, R., Balestrieri, M., Puglisi, F. (2008). Cognitive functions and elderly cancer patients receiving anti-cancer treatment: A prospective study. Critical Reviews in Oncology/Hematology, 67, 71-79. doi:10.1016/j.critrevonc.2008.02.004
37. Ouimet, L. A., Stewart, A., Collins, B., Schindler, D., & Bielajew, C. (2009). Measuring neuropsychological change following breast cancer treatment: An analysis of statistical models. Journal of Clinical and Experimental Neuropsychology, 31, 73-89. doi:10.1080/13803390801992725
38. Palmer, J. L., Trotter, T., Joy, A. A., & Carlson, L. E. (2008). Cognitive effects of tamoxifen in pre-menopausal women with breast cancer compared to healthy controls. Journal of Cancer Survivorship, 2, 275-282. doi:10.1007/s11764-008-0070-1
39. Poppelreuter, M.,Weis, J., Külz, A. K., Tucha, O., Lange, K. W., & Bartsch, H. H. (2004). Cognitive dysfunction and subjective complaints of cancer patients: A cross-sectional study in a cancer rehabilitation centre. European Journal of Cancer, 40, 43-49. doi:10.1006/j.ejca.2003.08.001
40. Quesnel, C., Savard, J., & Ivers, H. (2009). Cognitive impairments associated with breast cancer treatments: Results from a longitudinal study. Breast Cancer Research and Treatment, 116, 113-123. doi:10.1007/s10549-008-0114- 2
41. Schagen, S. B., Muller, M. J., Boogerd, W., Mellenbergh, G. J., & van Dam, F. S. A. M. (2006). Change in cognitive function after chemotherapy: A prospective longitudinal study in breast cancer patients. Journal of the National Cancer Institute, 98, 1742-1745. doi:10.1093/jnci/djj470
42. Schagen, S. B., van Dam, F., Muller, M. J., Boogerd, W., Lindeboom, J., & Bruning, P. F. (1999). Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer, 85, 640-650.
43. Scherling, C., Collins, B., MacKenzie, J., Bielajew, C., & Smith, A. (2011). Pre-chemotherapy differences in visuo-spatial working memory in breast cancer patients compared to controls: An fMRI study. Frontiers in Human Neuroscience, 5, 122. doi:10.3389/fnhum.2011.00122
44. Schilder, C. M., Seynaeve, C., Beex, L. V., Boogerd, W., Linn, S. C., Gundy, C. M., Schagen, S. B. (2010). Effects of tamoxifen and exemestane on cognitive functioning of postmenopausal patients with breast cancer: Results from the neuropsychological side study of the Tamoxifen and Exemestane Adjuvant Multinational Trial. Journal of Clinical Oncology, 28, 1294-1300. doi:10.1200/JCO.2008.21.3553
45. Schilder, C. M., Seynaeve, C., Linn, S. C., Boogerd, W., Gundy, C. M., Beex, L. V., Schagen, S. B. (2010). The impact of different definitions and reference groups on the prevalence of cognitive impairment: A study in postmenopausal breast cancer patients before the start of adjuvant systemic therapy. Psycho-Oncology, 19, 415-422. doi:10.1002/pon.1595
46. Shilling, V., Jenkins, V., Fallowfield, L., & Howell, T. (2003). The effects of hormone therapy on cognition in breast cancer. Journal of Steroid Biochemistry and Molecular Biology, 86, 405-412. doi:10.1016/j.jsbmb. 2003.07.001
47. Shilling, V., Jenkins, V., Morris, R., Deutsch, G., & Bloomfield, D. (2005). The effects of adjuvant chemotherapy on cognition in women with breast cancer - Preliminary results of an observational longitudinal study. The Breast, 14, 142-150. doi:10.1016/j. breast.2004.10.004
48. Shilling, V., Jenkins, V., & Trapala, I. S. (2006). The (mis)classification of chemo-fog - Methodological inconsistencies in the investigation of cognitive impairment after chemotherapy. Breast Cancer Research and Treatment, 95, 125-129. doi:10.1007/s10549-005-9055-1
49. Stewart, A., Collins, B., MacKenzie, J., Tomiak, E., Verma, S., & Bielajew, C. (2008). The cognitive effects of adjuvant chemotherapy in early stage breast cancer: A prospective study. Psycho-Oncology, 17, 122-130. doi:10.1002/pon.1210.
50. Tager, F., McKinley, P. S., Schnabel, F. R., El-Tamer, M., Cheung, Y. K., Fang, Y., Hershman, D. L. (2010). The cognitive effects of chemotherapy in post-menopausal breast cancer patients: A controlled longitudinal study. Breast Cancer Research and Treatment, 123, 25-34. doi:10.1007/s10549-009-060608
51. Tate, R. N., Perdices, M., & Maggiotto, S. (1998). Stability of the Wisconsin Card Sorting Test and the determination of reliability of change in scores. Clinical Neuropsychologist, 12, 348-357. doi:10.1076/clin.12.3.348.1998
52. Tchen, N., Juffs, H. G., Downie, F. P., Yi, Q. L., Hu, H., Chemerynsky, I., Tannock, I. F. (2003). Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. Journal of Clinical Oncology, 21, 4175-4183. doi:10.1200/JCO.2003.01.119
53. Temkin, N. R., Heaton, R. K., Grant, I., & Dikmen, S. S. (1999). Detecting significant change in neuropsychological test performance: A comparison of four models. Journal of the International Neuropsychological Society, 5, 357-369.
54. van Dam, F., Schagen, S. B., Muller, M. J., Boogerd, W., Wall, E., Droogleever Fortuyn,M. E., Rodenhuis, S. (1998). Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: High-dose versus standard-dose chemotherapy. Journal of the National Cancer Institute, 90, 210-218. doi:10.1093/jnci/90.3.210
55. Vardy, J., Wefel, J. S., Ahles, T., Tannock, I. F., & Schagen, S. B. (2008). Cancer and cancertherapy related cognitive dysfunction: An international perspective from the Venice cognitive workshop. Annals of Oncology, 19, 623-629. doi:10.1093/annonc/mdm500
56. Vearncombe, K. J., Rolfe, M., Wright, M., Pachana, N. A., Andrew, B., & Beadle, G. (2009). Predictors of cognitive decline after chemotherapy in breast cancer patients. Journal of the International Neuropsychological Society, 15, 951-962. doi:10.1017/S1355617709990567
57. Wechsler, D. (1997a). Wechsler Adult Intelligence Scale (3rd ed.). San Antonio, TX: Harcourt, Brace.
58. Wechsler, D. (1997b). Wechsler Memory Scale (3rd ed.). San Antonio, TX: Harcourt, Brace.
59. Wefel, J. S., Lenzi, R., Theriault, R. L., Buzdar, A. U., Cruickshank, S., & Meyers, C. A. (2004). "Chemobrain" in breast carcinoma? A prologue. Cancer, 101, 466-475. doi:10.1002/cncr.20393
60. Wefel, J. S., Lenzi, R., Theriault, R. L., Davis, R. N., & Meyers, C. A. (2004). The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma. Cancer, 100, 2292-2299. doi:10.1002/cncr.20272
61. Wefel, J. S., Saleeba, A. K., Buzdar, A. U., & Meyers, C. A. (2010). Acute and late-onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer, 116, 3348-3356. doi:10.1002/cncr.25098
62. Wefel, J. S., Vardy, J., Ahles, T., & Schagen, S. B. (2011). International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncology, 12, 703-708. doi:10.1016/S1470-2045(10)70294-1
63. Wienecke, M. H., & Dienst, E. R. (1995). Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psycho-Oncology, 4, 61-66. doi:10.1002/pon.2960040108
64. Woods, S. P., Childers, M., Ellis, R. J., Guaman, S., Grant, I., & Heaton, R. K. (2006). A battery approach for measuring neuropsychological change. Archives of Clinical Neuropsychology, 21, 83-89. doi:10.1016/j. acn.2005.07.008.